RT for Adenocarcinoma/Adenosquamous Carcinoma

计划入组 60 人 · 首次发布于 2025 年 9 月 4 日

RT for Cervical Adenocarcinoma/adenosquamous Carcinoma

计划入组 400 人 · 首次发布于 2024 年 12 月 18 日

Superenhancer Inhibitor Minnelide in Advanced Refractory Adenosquamous Carcinoma of the Pancreas (ASCP)

计划入组 16 人 · 首次发布于 2021 年 5 月 21 日

hepatocellular carcinoma program

Hepatocellular carcinoma(Engitix)

renal cell carcinoma program

Senti Biosciences, Inc.

United States

Breakthrough Immunotherapy Response in Rare Lung Adenosquamous Carcinoma with Multiple Driver Mutations

Cellular Map of Healthy Pancreas Reveals Origins of Aggressive Tumors, Challenging One-Size-Fits-All Treatment

Pembrolizumab Plus Chemoradiotherapy Significantly Improves Survival in High-Risk Cervical Cancer